Overall survival benefit from tebentafusp in patients with best response of progressive disease Meeting Abstract
| Authors: | Joshua, A. M.; Baurain, J. F.; Piperno-Neumann, S.; Nathan, P.; Hassel, J. C.; Butler, M. O.; Schlaak, M.; Sullivan, R.; Ochsenreither, S.; Dummer, R.; Kirkwood, J. M.; Sacco, J. J.; Shoushtari, A. N.; Orloff, M.; Piulats, J. M.; Abdullah, S. E.; Deo, M.; Lockwood, S.; Rutkowski, P. |
| Abstract Title: | Overall survival benefit from tebentafusp in patients with best response of progressive disease |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120605113 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.9509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9509 -- Source: Wos |
